Nevada 2019 Regular Session Status: Enacted

SB 378 — Revises provisions relating to prescription drugs. (BDR 18-574)

Last action — Chapter 616.

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. ✓
    Passed Senate
  4. ✓
    Passed Assembly
  5. ✓
    To Executive
  6. 6
    Enacted

This bill has been enacted into law. Introduced March 20, 2019. Enacted.

Prognosis

Advancing 50% · moderate confidence

Where this bill stands today.

Odds of enactment

High

How often bills like it became law.

  • Enacted

    Current position in the legislative process.

  • 1 sponsor

    1 primary, 0 co-sponsors signed on.

Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.

Summary

AN ACT relating to prescription drugs; revising provisions concerning coverage of prescription drugs under Medicaid and the Children's Health Insurance Program; revising provisions governing restrictions imposed on the list of preferred prescription drugs to be used for the Medicaid program; revising the criteria for selecting prescription drugs for inclusion on the list; replacing the Pharmacy and Therapeutics Committee with the Silver State Scripts Board; authorizing certain public and nonprofit insurers to use the preferred prescription drug list for Medicaid as their formulary; revising provisions governing the duties of pharmacy benefit managers; and providing other matters properly relating thereto.

Bill Text

What changed in the latest version

557 added · 611 removed

557 line(s) added, 611 removed.

→
Previous
Latest
EXEMPT (Reprinted with amendments adopted on May 30, 2019) SECOND REPRINT S.B.
Senate Bill No.
378 SENATE B ILLN O.
378–Senator Cancela CHAPTER..........
378–SENATOR C ANCELA M ARCH 20, 2019 ____________ Referred to Committee on Health and Human Services SUMMARY—Revises provisions relating to prescription drugs.
(BDR 18-574) FISCAL NOTE:
Effect on Local Government:
No.
Effect on the State:
Yes.
~ EXPLANATION – Matter in bolded italics is new;
matter between brackets [omitted material] is material to be omitted.
Section 31.15 additionally requires any health maintenance organization that enters into such a contract with the Department to provide all rebates received through the purchase of prescription drugs pursuant to does not enter into such a contract, section 31.15 also requires the Department tot directly manage and coordinate such services.
Section 31.15 additionally requires any health maintenance organization that enters into such a contract with the Department to provide all rebates received through the purchase of prescription drugs pursuant to the contract to the Department, except for an administrative fee.
Section 31.2 of this bill provides for - *SB378_R2* – 2 – an annual audit of any contract between the Department and a pharmacy benefit manager or health maintenance organization entered into pursuant to section 31.15.
If the Department does not enter into such a contract, section 31.15 also requires the Department to an annual audit of any contract between the Department and a pharmacy benefitdes for manager or health maintenance organization entered into pursuant to section 31.15.
and (2) a list of preferred prescription drugs on the list of preferred prescription drugs to be used for the Section 31.4 of this bill requires the Children’s Health Insurance Program to use the list of preferred prescription drugs.
and (2) a list of preferred prescription drugs on the list of preferred prescription drugs to be used for the Medicaid program that are not subject to certain restrictions.
Sections 28.5, 29.3, 31.4 and 33 of this bill authorize other public and nonprofit insurance plans to use the list of preferred prescription drugs as the formulary for such plans.
(NRS 422.4025) Section 31.4 of this bill requires the Children’s Health Insurance Program to use authorize other public and nonprofit insurance plans to use the list of preferreds bill prescription drugs as the formulary for such plans.
Section 31.4 also requires the Department to negotiate and enter into agreements to purchase prescription drugs included on the list of preferred prescription drugs on behalf of those health benefit plans or enter into a contract with a pharmacy benefit manager or health maintenance organization, as appropriate, to negotiate and enter into such drugs from the list of preferred prescription drugs to be used for the Medicaidn program that are not subject to certain restrictions.
Section 31.4 also requires the Department to negotiate and enter into agreements to purchase prescription drugs included on the list of preferred prescription drugs on behalf of those health benefit plans or enter into a contract with a pharmacy benefit manager or health maintenance organization, as appropriate, to negotiate and enter into such agreements.
Existing law requires the Director of the Department to create a Pharmacy and Therapeutics Committee within the Department, consisting of members appointed by the Governor based on recommendations of the Director.
Section 31.4 of this bill removes certain categories of prescription program that are not subject to certain restrictions.o be used for the Medicaid Existing law requires the Director of the Department to create a Pharmacy and Therapeutics Committee within the Department, consisting of members appointed by the Governor based on recommendations of the Director.
(NRS 422.4035) Existing law requires the Committee to identify:
(NRS 422.4035) - 80th Session (2019) – 2 – Existing law requires the Committee to identify:
and (2) prescription drugs on that list which should be excluded from any restrictions replace the Committee with the Silver State Scripts Board.
and (2) imposed by the Medicaid program.
(NRS 422.405) Sections 31.55-31.8 of this bill replace the Committee with the Silver State Scripts Board.
and (2) assume the other duties of the Committee.
and (2) assume the Existing law requires the Committee to make its decisions based on evidence of clinical efficacy and safety without consideration of cost.
Existing law requires the Committee to make its decisions based on evidence of clinical efficacy and safety without consideration of cost.
(NRS 422.405) Section 31.8 of this bill authorizes the Board to consider cost if there is no significant difference in the clinical efficacy, safety and patient outcomes of two or more drugs.
(NRS 422.405) Section difference in the clinical efficacy, safety and patient outcomes of two or moreant drugs.
Sections 25, 29.2, 31-31.1, 31.3, 31.35, 31.45 and 31.9 of this bill make conforming changes.
Sections changes., 31-31.1, 31.3, 31.35, 31.45 and 31.9 of this bill make conforming Under existing law, a pharmacy benefit manager has a fiduciary duty to a third party with which the pharmacy benefit manager has entered into a contract to manage the pharmacy benefits plan of the third party.
Under existing law, a pharmacy benefit manager has a fiduciary duty to a third party with which the pharmacy benefit manager has entered into a contract to manage the pharmacy benefits plan of the third party.
(NRS 683A.178) Section 32.5 of this bill removes this fiduciary duty and instead imposes on a pharmacy benefit manager an obligation of good faith and fair dealing toward a third party or contractual provision that limits or waives that obligation is void and that any unenforceable.
(NRS 683A.178) Section benefit manager an obligation of good faith and fair dealing toward a third party or pharmacy when performing contractual duties.
EXPLANATION – Matter in bolded italics is new;
Section 32.5 also provides that any contractual provision that limits or waives that obligation is void and unenforceable.
matter between brackets [omitted material] is material to be omitted.
Section 1.
Sections 1-24.
2.
(Deleted by amendment.) Sec.
3.
(Deleted by amendment.) - *SB378_R2* – 3 – Sec.
4.
(Deleted by amendment.) Sec.
5.
(Deleted by amendment.) Sec.
6.
(Deleted by amendment.) Sec.
7.
(Deleted by amendment.) Sec.
8.
Show all 207 changed rows (167 more)
Previous
Latest
(Deleted by amendment.) Sec.
9.
(Deleted by amendment.) Sec.
10.
(Deleted by amendment.) Sec.
11.
(Deleted by amendment.) Sec.
11.5.
(Deleted by amendment.) Sec.
12.
(Deleted by amendment.) Sec.
13.
(Deleted by amendment.) Sec.
14.
(Deleted by amendment.) Sec.
15.
(Deleted by amendment.) Sec.
16.
(Deleted by amendment.) Sec.
17.
(Deleted by amendment.) Sec.
18.
(Deleted by amendment.) Sec.
19.
(Deleted by amendment.) Sec.
20.
(Deleted by amendment.) Sec.
21.
(Deleted by amendment.) Sec.
22.
(Deleted by amendment.) Sec.
23.
(Deleted by amendment.) Sec.
24.
(Deleted by amendment.) Sec.
(a) Shall.
232.320 1.
appoint,ctwith the consent of the Governor, administrators of the divisions of the Department, who are respec(1) The Administrator of the Aging and Disability Services Division;
The Director:
(a) Shall appoint, with the consent of the Governor, administrators of the divisions of the Department, who are respectively designated as follows:
(1) The Administrator of the Aging and Disability Services Division;
(b) Shall administer, through the divisions of the Department, the provisions of chapters 63, 424, 425, 427A, 432A to 442, inclusive, 446 to 450, inclusive, 458A and 656A of NRS, NRS 127.220 to 127.310, inclusive, 422.001 to 422.410, inclusive, and sections 31.05 to 31.2, inclusive, of this act, 422.580, 432.010 to 432.133, inclusive, 432B.621 to 432B.626, inclusive, 444.002 to 444.430, inclusive, and 445A.010 to 445A.055, inclusive, and all other provisions of law relating to the functions of the divisions of - *SB378_R2* – 4 – the Department, but is not responsible for the clinical activities of the Division of Public and Behavioral Health or the professional line activities of the other divisions.
- 80th Session (2019) – 3 – (b) Shall administer, through the divisions of the Department, the provisions of chapters 63, 424, 425, 427A, 432A to 442, inclusive, 446 to 450, inclusive, 458A and 656A of NRS, NRS 127.220 to 127.310, inclusive, 422.001 to 422.410, inclusive, and sections 31.05 to 31.2, inclusive, of this act, 422.580, 432.010 to 432.133, inclusive, 432B.621 to 432B.626, inclusive, 444.002 to 444.430, inclusive, and 445A.010 to 445A.055, inclusive, and all other provisions of law relating to the functions of the divisions of the Department, but is not responsible for the clinical activities of activities of the other divisions.ral Health or the professional line (c) Shall administer any state program for persons with developmental disabilities established pursuant to the Developmental Disabilities Assistance and Bill of Rights Act of 2000, 42 U.S.C.
(c) Shall administer any state program for persons with developmental disabilities established pursuant to the Developmental Disabilities Assistance and Bill of Rights Act of 2000, 42 U.S.C.
(4) Identify the sources of funding for services provided by the Department and the allocation of that funding;
(4) Identify the sources of funding for services provided by the Dep(5) Set forth sufficient information to assist the Department in providing those services and in the planning and budgeting for the future provision of those services;
(5) Set forth sufficient information to assist the Department future provision of those services;
and (6) Contain any other information necessary for the Department to communicate effectively with the Federal Government concerning demographic trends, formulas for the distribution of federal money and any need for the modification of programs administered by the Department.
andplanning and budgeting for the (6) Contain any other information necessary for the Government concerning demographic trends, formulas for theederal distribution of federal money and any need for the modification of programs administered by the Department.
(e) May, by regulation, require nonprofit organizations and state and local governmental agencies to provide information regarding the programs of those organizations and agencies, excluding detailed information relating to their budgets and payrolls, which the - 80th Session (2019) – 4 – Director deems necessary for the performance of the duties imposed upon him or her pursuant to this section.
(e) May, by regulation, require nonprofit organizations and state and local governmental agencies to provide information regarding the programs of those organizations and agencies, excluding detailed information relating to their budgets and payrolls, which the Director deems necessary for the performance of the duties imposed upon him or her pursuant to this section.
Sec.
Secs.
26.
26 and 27.
(Deleted by amendment.) Sec.
(Deleted by amendment.) 241.016 1.
27.
The meetings of a public body that are quasi-s:
(Deleted by amendment.) - *SB378_R2* – 5 – Sec.
judicial in nature are subject to the provisions of this chapter.
28.
NRS 241.016 is hereby amended to read as follows:
241.016 1.
The meetings of a public body that are quasi- judicial in nature are subject to the provisions of this chapter.
Any provision of law, including, without limitation, NRS 91.270, 219A.210, 228.495, 239C.140, 281A.350, 281A.690, 281A.735, 281A.760, 284.3629, 286.150, 287.0415, 287.04345, 287.338, 288.220, 289.387, 295.121, 360.247, 388.261, 388A.495, 388C.150, 388G.710, 388G.730, 392.147, 392.467, 394.1699, 396.3295, 422.405, 433.534, 435.610, 463.110, 622.320, 622.340, 630.311, 630.336, 631.3635, 639.050, 642.518, 642.557, 686B.170, 696B.550, 703.196 and 706.1725, which:
Any provision of law, including, without limitation, NRS 91.270, 219A.210, 228.495, 239C.140, 281A.350, 281A.690, 281A.735, 281A.760, 284.3629, 286.150, 287.0415, 287.04345, 287.338, 288.220, 289.387, 295.121, 360.247, 388.261, 388A.495, 388C.150, 388G.710, 388G.730, 392.147, 392.467, 394.1699, 396.3295, 422.405, 433.534, 435.610, 463.110, 622.320, 622.340, 630.311, 630.336, 631.3635, 639.050, 642.518, 642.557, 686B.170, 696(a) Provides that any meeting, hearing or other proceeding is not subject to the provisions of this chapter;
(a) Provides that any meeting, hearing or other proceeding is not subject to the provisions of this chapter;
or (b) Otherwise authorizes or requires a closed meeting, hearing or proceeding, prevails over the general provisions of this chapter.
or or proceeding,se authorizes or requires a closed meeting, hearing prevails over the general provisions of this chapter.
4.
communication, must not be used to circumvent the spirit or letter of this chapter to deliberate or act, outside of an open and public meeting, upon a matter over which the public body has supervision, control, jurisdiction or advisory powers.
The exceptions provided to this chapter, and electronic communication, must not be used to circumvent the spirit or letter of this chapter to deliberate or act, outside of an open and public meeting, upon a matter over which the public body has supervision, control, jurisdiction or advisory powers.
Sec.
- 80th Session (2019) – 5 – Sec.
A governing body of a county, school district, municipal corporation, political subdivision, public corporation or other local governmental agency of the State of Nevada that provides coverage of prescription drugs pursuant to NRS 287.010 or any issuer of a policy of health insurance purchased pursuant to NRS 287.010 may use the list of preferred prescription drugs developed by the Department of Health and Human Services pursuant to subsection 1 of NRS 422.4025 as its formulary and obtain prescription drugs through the purchasing agreements negotiated by the Department pursuant to that section by notifying the Department in the form prescribed by the Department.
A governing body of a county, school district, municipal corporation, political subdivision, public corporation or other local governmental agency of the State of Nevada that provides coverage of prescription drugs pursuant to NRS 287.010 or any issuer of a policy of health insurance purchased pursuant to NRS 287.010 may use the list of preferred prescription drugs developed by the Department of Health and Human Services pursuant to prescription drugs through the purchasing agreements negotiated by the Department pursuant to that section by notifying the Department in the form prescribed by the Department.
(Deleted by amendment.) - *SB378_R2* – 6 – Sec.
(Deleted by amendment.) Sec.
287.040 The provisions of NRS 287.010 to 287.040, inclusive, and section 28.5 of this act do not make it compulsory upon any governing body of any county, school district, municipal corporation, political subdivision, public corporation or other local governmental agency of the State of Nevada, except as otherwise provided in NRS 287.021 or subsection 4 of NRS 287.023 or in an agreement entered into pursuant to subsection 3 of NRS 287.015, to pay any premiums, contributions or other costs for group insurance, a plan of benefits or medical or hospital services established pursuant to NRS 287.010, 287.015, 287.020 or paragraph (b), (c) or (d) of subsection 1 of NRS 287.025, for coverage under the Public Employees’ Benefits Program, or to make any contributions to a trust fund established pursuant to NRS 287.017, or upon any officer or employee of any county, school district, municipal corporation, political subdivision, public corporation or other local governmental agency of this State to accept any such coverage or to assign his or her wages or salary in payment of premiums or contributions therefor.
287.040 The provisions of NRS 287.010 to 287.040, inclusive, and section 28.5 of this act do not make it compulsory upon any governing body of any county, school district, municipal corporation, political subdivision, public corporation or other local governmental agency of the State of Nevada, except as otherwise provided in NRS 287.021 or subsection 4 of NRS 287.023 or in an agreement entered into pursuant to subsection 3 of NRS 287.015, to pay any premiums, contributions or other costs for group insurance, a plan of benefits or medical or hospital services established pursuant to NRS 287.010, 287.015, 287.020 or paragraph (b), (c) or (d) of subsection 1 of NRS 287.025, for coverage under the Public Employees’ Benefits Program, or to make any contributions to a trust fund established pursuant to NRS 287.017, or upon any officer or employee of any county, school district, municipal corporation, agency of this State to accept any such coverage or to assign his orl her wages or salary in payment of premiums or contributions therefor.
The Board may establish a plan of life, accident or health insurance and provide for the payment of contributions of benefits from the Program Fund.
The Board may establish a plan of life, accident or health insurance and provide for the payment of contributions into the Program Fund, a schedule of benefits and the disbursement of benefits from the Program Fund.
The Board may reinsure anyement risk or any part of such a risk.
The Board may reinsure any risk or any part of such a risk.
pursuant to this section, the Board or any entity with which the Board enters into a contract to provide such coverage may use the list of preferred prescription drugs developed by the Department of Health and Human Services pursuant to subsection 1 of NRS 422.4025 as its formulary and obtain prescription drugs through the purchasing agreements negotiated by the Department pursuant to that section by notifying the Department in the form prescribed by the Department.
2.
If the Board provides coverage of prescription drugs pursuant to this section, the Board or any entity with which the Board enters into a contract to provide such coverage may use the - 80th Session (2019) – 6 – list of preferred prescription drugs developed by the Department of Health and Human Services pursuant to subsection 1 of NRS 422.4025 as its formulary and obtain prescription drugs through the purchasing agreements negotiated by the Department pursuant to that section by notifying the Department in the form prescribed by the Department.
29.6.
29.6 and 30.
30.
(Deleted by amendment.) Sec.
Chapter 422 of NRS is hereby amended by adding thereto the provisions set forth as sections 31.05 to 31.2, inclusive, of this act.
Chapter 422 of NRS is hereby amended by adding thereto the provisions set forth as sections 31.05 to 31.2, inclusive, of Sec.
Sec.
- *SB378_R2* – 7 – Sec.
Sec.
(b) A health maintenance organization pursuant to NRS 422.273 for the provision of any of the services described in subsection 1 for recipients of Medicaid or recipients of insurance through the Children’s Health Insurance Program who receive coverage through a Medicaid managed care program.
(b) A health maintenance organization pursuant to NRS 422.273 for the provision of any of the services described in subsection 1 for recipients of Medicaid or recipients of insurance coverage through a Medicaid managed care program.ho receive 3.
3.
and (b) Require the pharmacy benefit manager or health maintenance organization, as applicable, to disclose to the Department any information relating to the services covered by the contract, including, without limitation, information concerning and paid and any fees and charges imposed by the pharmacyes collected benefit manager or health maintenance organization pursuant to the4.onIn addition to meeting the requirements of subsection 3, a contract entered into pursuant to:
and (b) Require the pharmacy benefit manager or health maintenance organization, as applicable, to disclose to the Department any information relating to the services covered by the contract, including, without limitation, information concerning dispensing fees, measures for the control of costs, rebates collected and paid and any fees and charges imposed by the pharmacy benefit manager or health maintenance organization pursuant to the contract.
- 80th Session (2019) – 7 – 4.
In addition to meeting the requirements of subsection 3, a contract entered into pursuant to:
(b) Paragraph (b) of subsection 2 must require the health maintenance organization to provide to the Department the entire amount of any rebates received for the purchase of prescription drugs, including, without limitation, rebates for the purchase of prescription drugs by an entity other than the Department, less an administrative fee in an amount prescribed by the contract.
(b) Paragraph (b) of subsection 2 must require the health maintenance organization to provide to the Department the entire drugs, including, without limitation, rebates for the purchase of prescription drugs by an entity other than the Department, less an administrative fee in an amount prescribed by the contract.
Any contract between the Department and a pharmacy benefit manager or health maintenance organization entered into pursuant to section 31.15 of this act must require the - *SB378_R2* – 8 – pharmacy benefit manager or health maintenance organization, as applicable, to:
Any contract between the Department and a pharmacy benefit manager or health maintenance organization entered into pursuant to section 31.15 of this act must require the pharmacy benefit manager or health maintenance organization, as applicable, to:
(b) Obtain from an independent accountant, at the expense of the pharmacy benefit manager or health maintenance organization, as applicable, an annual audit of internal controls to ensure the integrity of financial transactions and claims processing.
(b) Obtain from an independent accountant, at the expense of the pharmacy benefit manager or health maintenance ensure the integrity of financial transactions and claimscontrols to processing.
422.401 As used in NRS 422.401 to 422.406, inclusive, and sections 31.05 to 31.2, inclusive of this act, unless the context otherwise requires, the words and terms defined in NRS 422.4015 and 422.402 and sections 31.05 and 31.1 of this act have the meaSec.
422.401 As used in NRS 422.401 to 422.406, inclusive, and sections 31.05 to 31.2, inclusive of this act, unless the context otherwise requires, the words and terms defined in NRS 422.4015 and 422.402 and sections 31.05 and 31.1 of this act have the meanings ascribed to them in those sections.
- 80th Session (2019) – 8 – Sec.
Therapeutics Committee] Silver State Scripts Board established pursuant to NRS 422.4035.
422.4015 [“Committee”] “Board” means the [Pharmacy and Therapeutics Committee] Silver State Scripts Board established pursuant to NRS 422.4035.
(a) By regulation, develop a list of preferred prescription drugs to be used for the Medicaid program [.] and the Children’s Health Insurance Program, and each public or nonprofit health benefit plan that elects to use the list of preferred prescription drugs as its formulary pursuant to NRS 287.0433 or section 28.5 or 33 of this act;
(a) By regulation, develop a list of preferred prescription drugs Insurance Program, and each public or nonprofit health benefitlth plan that elects to use the list of preferred prescription drugs as its formulary pursuant to NRS 287.0433 or section 28.5 or 33 of this act;
- *SB378_R2* – 9 – 2.
2.
(b)] Prescription drugs that are prescribed for the treatment of the human immunodeficiency virus or acquired immunodeficiency syndrome, including, without limitation, protease inhibitors and antiretroviral medications;
the human immunodeficiency virus or acquired immunodeficiencyent of syndrome, including, without limitation, protease inhibitors and antiretroviral medications;
on the list of preferred prescription drugs and is excluded from any restrictions that are imposed by the Medicaid program on drugs that are(b) Which therapeutically equivalent prescription drugs will be reviewed for inclusion on the list of preferred prescription drugs and for exclusion from any restrictions that are imposed by the Medicaid program on drugs that are on the list of preferred prescription drugs;
- 80th Session (2019) – 9 – (a) Whether a class of therapeutic prescription drugs is included on the list of preferred prescription drugs and is excluded from any restrictions that are imposed by the Medicaid program on drugs that are on the list of preferred prescription drugs;
and (c) Which prescription drugs should be excluded from any restrictions that are imposed by the Medicaid program on drugs that are on the list of preferred prescription drugs based on continuity of care concerning a specific diagnosis, condition, class of therapeutic prescription drugs or medical specialty.
(b) Which therapeutically equivalent prescription drugs will be reviewed for inclusion on the list of preferred prescription drugs and for exclusion from any restrictions that are imposed by the Medicaid program on drugs that are on the list of preferred prescription drugs;
and restrictions that are imposed by the Medicaid program on drugs that are on the list of preferred prescription drugs based on continuity of care concerning a specific diagnosis, condition, class of therapeutic prescription drugs or medical specialty.
- *SB378_R2* – 10 – (a) Compile a report concerning the agreements negotiated pursuant to paragraph (b) of subsection 1 and contracts entered into pursuant to section 31.15 of this act which must include, without limitation, the financial effects of obtaining prescription drugs through those agreements and contracts, in total and aggregated separately for agreements negotiated by the Department, contracts with a pharmacy benefit manager and contracts with a health maintenance organization;
(a) Compile a report concerning the agreements negotiated pursuant to paragraph (b) of subsection 1 and contracts entered into pursuant to section 31.15 of this act which must include, without limitation, the financial effects of obtaining prescription drugs through those agreements and contracts, in total and aggregated separately for agreements negotiated by the Department, contracts with a pharmacy benefit manager and con(b) Post the report on an Internet website maintained by the Department and submit the report to the Director of the Legislative Counsel Bureau for transmittal to:
and (b) Post the report on an Internet website maintained by the Department and submit the report to the Director of the Legislative Counsel Bureau for transmittal to:
(a) Advise the Department concerning the use by the Medicaid program of step therapy and prior authorization for prescription drugs;
- 80th Session (2019) – 10 – (a) Advise the Department concerning the use by the Medicaid program of step therapy and prior authorization for prescription drugs;
(b) Develop step therapy protocols and prior authorization prescription drugs;
(b) Develop step therapy protocols and prior authorization policies and procedures for use by the Medicaid program for prescription drugs;
and for use by the Medicaid program for (c) Review and approve, based on clinical evidence and best the prescription drugs being considered, step therapy protocols usedf by the Medicaid program for prescription drugs.
and (c) Review and approve, based on clinical evidence and best clinical practice guidelines and without consideration of the cost of the prescription drugs being considered, step therapy protocols used by 3.
3.
The [Committee] Board must consist of [at least 5] - *SB378_R2* – 11 – such members [and not more than 11 members] as are appointed by the [Governor based on recommendations from the] Director.
The [Committee] Board must consist of [at least 5] such members [and not more than 11 members] as are appointed by the [Governor based on recommendations from the] Director.
The [Governor] Director shall appoint to the [Committee] Board health care professionals who have knowledge and expertise in one or more of the following:
The [Governor] Director shall appoint to the [Committee] Board health care professionals who have knowledge and expertise in (a) Themoreclinicallyllappropriate prescribing of outpatient prescription drugs that are covered by Medicaid;
(a) The clinically appropriate prescribing of outpatient prescription drugs that are covered by Medicaid;
At least one-third of the members of the [Committee] Board must be either active pharmacists registered in this State or persons in this State with doctoral degrees in pharmacy.
At least one-third of the members of the [Committee] Board must be either active pharmacists registered - 80th Session (2019) – 11 – in this State or persons in this State with doctoral degrees in pharmacy.
Sec.
31.6.
NRS 422.404 is hereby amended to read as follows:
The [Governor] Director shall appoint the Chairs:
The [Governor] Director shall appoint the Chair of the [Committee] Board from among its members.
of the [Committee] Board from among its members.
A member may be reappointed.f the 3.
A member may be reappointed.
the 3.
- *SB378_R2* – 12 – 2.
2.
Each member of the [Committee] Board who is an officer or employee of the State of Nevada or a local government must be relieved from his or her duties without loss of regular compensation so that the person may prepare for and attend meetings of the [Committee] Board and perform any work necessary to carry out the duties of the [Committee] Board in the most timely manner practicable.
Each member of the [Committee] Board who is an officer or relieved from his or her duties without loss of regular compensation so that the person may prepare for and attend meetings of the [Committee] Board and perform any work necessary to carry out the duties of the [Committee] Board in the most timely manner practicable.
Sec.
- 80th Session (2019) – 12 – Sec.
(a) Identifying the prescription drugs which should be included on the list of preferred prescription drugs developed by the Department [for the Medicaid program] pursuant to NRS 422.4025 [and] , which must include, without limitation, any prescription drug required by the Centers for Medicare and Medicaid Services of the United States Department of Health and Human Services to be covered by the Medicaid program and any other prescription dru(b) Identifying the prescription drugs which should be excluded from any restrictions that are imposed by the Medicaid program on dru[(b)] (c) Identifying classes of therapeutic prescription drugs for its review and performing a clinical analysis of each drug included in each class that is identified for review;
(a) Identifying the prescription drugs which should be included on the list of preferred prescription drugs developed by the Department [for the Medicaid program] pursuant to NRS 422.4025 [and] , which must include, without limitation, any prescription drug required by the Centers for Medicare and Medicaid Services be covered by the Medicaid program and any other prescriptionto drug deemed essential by the Board;
(b) Identifying the prescription drugs which should be excluded from any restrictions that are imposed by the Medicaid program on drugs that are on the list of preferred prescription drugs;
[(b)] (c) Identifying classes of therapeutic prescription drugs for its review and performing a clinical analysis of each drug included in each class that is identified for review;
(b) Review new pharmaceutical products in as expeditious a manner as possible;
manner as possible;
and (c) Consider new clinical evidence supporting the inclusion of an existing pharmaceutical product on the list of preferred - *SB378_R2* – 13 – prescription drugs developed by the Department [for the Medicaid program] and new clinical evidence supporting the exclusion of an existing pharmaceutical product from any restrictions that are imposed by the Medicaid program on drugs that are on the list of preferred prescription drugs in as expeditious a manner as possible.
andaceutical products in as expeditious a (c) Consider new clinical evidence supporting the inclusion of an existing pharmaceutical product on the list of preferred prescription drugs developed by the Department [for the Medicaid program] and new clinical evidence supporting the exclusion of an existing pharmaceutical product from any restrictions that are imposed by the Medicaid program on drugs that are on the list of preferred prescription drugs in as expeditious a manner as possible.
and (b) Establish subcommittees to analyze specific issues that arise as the [Committee] Board carries out its duties.
and - 80th Session (2019) – 13 – (b) Establish subcommittees to analyze specific issues that arise as the [Committee] Board carries out its duties.
(a) Adopt regulations;
(b) Enter into contracts for any services.
and (b) Enter into contracts for any services.
Any regulations adopted by the Department pursuant to NRS 422.27172 to 422.27178, inclusive, and 422.401 to 422.406, adopted in accordance with the provisions of chapter 241 of NRS.st be Sec.
Any regulations adopted by the Department pursuant to NRS 422.27172 to 422.27178, inclusive, and 422.401 to 422.406, inclusive, and sections 31.05 to 31.2, inclusive, of this act must be adopted in accordance with the provisions of chapter 241 of NRS.
Sec.
(Deleted by amendment.) follows:32.5.
(Deleted by amendment.) Sec.
NRS 683A.178 is hereby amended to read as 683A.178 1.
32.5.
NRS 683A.178 is hereby amended to read as follows:
683A.178 1.
A pharmacy benefit manager shall notify [the] a third party with which it has entered into a contract in writing of any activity, policy or practice of the pharmacy benefit manager that presents a conflict of interest that interferes with the [ability of the pharmacy benefit manager to discharge that fiduciary duty.] obligations imposed by subsection 1.
A pharmacy benefit manager shall notify [the] a third party with which it has entered into a contract in writing of any activity, policy or practice of the pharmacy benefit manager that presents a conflict of interest that interferes with the [ability of the pharmacy imposed by subsection 1.arge that fiduciary duty.] obligations Sec.
Sec.
A nonprofit health benefit plan may use the list of preferred prescription drugs developed by the Department of - *SB378_R2* – 14 – Health and Human Services pursuant to subsection 1 of NRS 422.4025 as its formulary and obtain prescription drugs through the purchasing agreements negotiated by the Department pursuant to that section by notifying the Department in the form prescribed by the Department.
A nonprofit health benefit plan may use the list of preferred prescription drugs developed by the Department of Health and Human Services pursuant to subsection 1 of NRS 422.4025 as its formulary and obtain prescription drugs through the purchasing agreements negotiated by the Department pursuant to that section by notifying the Department in the form prescribed by the Department.
Sec.
Secs.
34.
34-39.
(Deleted by amendment.) Sec.
(Deleted by amendment.) - 80th Session (2019) – 14 – Sec.
35.
(Deleted by amendment.) Sec.
35.5.
(Deleted by amendment.) Sec.
36.
(Deleted by amendment.) Sec.
36.1.
(Deleted by amendment.) Sec.
36.2.
(Deleted by amendment.) Sec.
36.3.
(Deleted by amendment.) Sec.
36.4.
(Deleted by amendment.) Sec.
36.5.
(Deleted by amendment.) Sec.
36.6.
(Deleted by amendment.) Sec.
36.8.
(Deleted by amendment.) Sec.
37.
(Deleted by amendment.) Sec.
38.
(Deleted by amendment.) Sec.
38.3.
(Deleted by amendment.) Sec.
38.5.
(Deleted by amendment.) Sec.
38.7.
(Deleted by amendment.) Sec.
39.
(Deleted by amendment.)t.) Sec.
Notwithstanding any other provision of law, the Committee established pursuant to NRS 422.4035, as that section exists on June 30, 2019, expire on that date.
Notwithstanding any other provision of law, the terms of the members appointed to the Pharmacy and Therapeutics Committee established pursuant to NRS 422.4035, as that section exists on June 30, 2019, expire on that date.
- *SB378_R2* – 15 – Sec.
Sec.
1.
regulations and performing any other preparatory administrativeny tasks that are necessary to carry out the provisions of this act;
Upon passage and approval for the purpose of adopting any regulations and performing any other preparatory administrative tas2.
and 2.
tOn January 1, 2020, for all other purposes.ns of this act;
On January 1, 2020, for all other purposes.
and H - *SB378_R2*
~~~~~ 19 - 80th Session (2019)
View plain text versions (4)

Amendments

2 amendments

Click Show changes on an amendment above to see how it modifies the bill.

Action History

  1. Chapter 616.

  2. Approved by the Governor.

  3. Enrolled and delivered to Governor.

  4. From committee: Do pass. Declared an emergency measure under the Constitution. Read third time. Passed. Title approved. (Yeas: 41, Nays: None, Vacant: 1.) To Senate. In Senate. To enrollment.

  5. In Assembly. Read first time. Referred to Committee on Ways and Means. To committee.

  6. From committee: Amend, and do pass as amended. Placed on General File. Read third time. Amended. (Amend. No. 1016.) Reprinting dispensed with. Read third time. Passed, as amended. Title approved, as amended. (Yeas: 19, Nays: None, Excused: 2.) To printer. From printer. To re-engrossment. Re-engrossed. Second reprint. To Assembly.

  7. From printer. To engrossment. Engrossed. First reprint. To committee. Exemption effective.

  8. From committee: Amend, and do pass as amended. Placed on Second Reading File. Read second time. Amended. (Amend. No. 275.) Re-referred to Committee on Finance. To printer.

  9. Notice of eligibility for exemption.

  10. From printer. To committee.

  11. Read first time. Referred to Committee on Health and Human Services. To printer.

Sponsors

  • Senator Yvanna Cancela · Primary

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 66 not signed on

Sponsors (1)

  • Senator Yvanna Cancela

Co-sponsors (0)

None.

Not signed on (66)

66 members have not signed on to this bill.

Show all 66 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does SB 378 do?
AN ACT relating to prescription drugs; revising provisions concerning coverage of prescription drugs under Medicaid and the Children's Health Insurance Program; revising provisions governing restrictions imposed on the list of preferred prescription drugs to be used for the Medicaid program; revising the criteria for selecting prescription drugs for inclusion on the list; replacing the Pharmacy and Therapeutics Committee with the Silver State Scripts Board; authorizing certain public and nonprofit insurers to use the preferred prescription drug list for Medicaid as their formulary; revising provisions governing the duties of pharmacy benefit managers; and providing other matters properly relating thereto.
Who sponsors SB 378?
SB 378 is sponsored by Senator Yvanna Cancela.
What is the current status of SB 378?
This bill has been enacted into law. Introduced March 20, 2019. Enacted.
Where can I track SB 378?
Track SB 378 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB 378

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Stay ahead of SB 378

Last checked for changes 2 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →